Dec 30, 2025 09:15AM
Dec 30, 2025 09:15AM
Sep 17, 2025 08:45AM
Sep 17, 2025 08:45AM
Sep 9, 2025 06:53AM
May 15, 2025 08:05AM
Apr 16, 2025 08:00AM Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Mar 20, 2025 08:35AM
Mar 20, 2025 08:35AM
Mar 3, 2025 09:02AM
Mar 3, 2025 09:00AM
Feb 19, 2025 09:00AM
Feb 3, 2025 08:00AM
Feb 3, 2025 08:00AM Akari Therapeutics Joins Webull Corporate Connect Service Platform
Dec 18, 2024 08:53AM
Dec 18, 2024 08:51AM
Dec 16, 2024 09:06AM
Dec 16, 2024 09:05AM
Nov 19, 2024 08:02AM
Nov 19, 2024 08:00AM
Nov 14, 2024 04:15PM Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
Nov 8, 2024 08:00AM
Nov 8, 2024 08:00AM
Oct 15, 2024 08:00AM
Sep 17, 2024 08:01AM
Sep 17, 2024 08:00AM
Aug 19, 2024 04:15PM
Aug 19, 2024 08:00AM Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy
Jun 5, 2024 08:00AM
Jun 4, 2024 08:01AM
Jun 4, 2024 08:00AM
May 16, 2024 08:00AM
May 1, 2024 08:01AM
May 1, 2024 08:01AM
May 1, 2024 08:00AM Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Apr 15, 2024 08:00AM
Apr 1, 2024 06:30AM
Mar 11, 2024 05:26PM
Mar 8, 2024 04:38PM
Mar 5, 2024 08:05AM
Mar 5, 2024 08:00AM
Mar 5, 2024 08:00AM Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Aug 2, 2023 08:00AM
May 16, 2023 04:05PM
May 1, 2023 08:00AM
May 1, 2023 08:00AM
Sep 27, 2022 08:00AM
Sep 27, 2022 08:00AM
Jul 20, 2022 06:00AM Akari Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Pipeline Progress
Jul 20, 2022 06:00AM

1,155,103 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All